cost effectiveness
ICER Finds Nanoscope Retinal Gene Therapy Cost Effective in $67,400 to $101,300 Price Range
Nanoscope Therapeutics has said it plans to seek regulatory approval for its advanced retinitis pigmentosa gene therapy MCO-010 early this year.
NICE Recommends Vertex, CRISPR Therapeutics' Casgevy for Sickle Cell Under Managed Access Deal
The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.
NICE Not Backing AstraZeneca, Daiichi Sankyo's Enhertu in HER2-Low Breast Cancer
Breast cancer patients in England and Wales will not have access to the drug after pricing negotiations failed between NICE and drugmakers.
NICE Recommends Vertex's Casgevy for Beta Thalassemia Through Innovative Medicines Fund
The agency is making the drug available through the IMF so that more data can be collected on its efficacy and cost-effectiveness.
After comparing the cost-effectiveness of giving the PARP inhibitor versus not, researchers found the treatment, though pricey, "provides a very good value."
Jun 27, 2016